CN111000913A - Traditional Chinese medicine composition for treating psoriasis - Google Patents

Traditional Chinese medicine composition for treating psoriasis Download PDF

Info

Publication number
CN111000913A
CN111000913A CN201910588043.9A CN201910588043A CN111000913A CN 111000913 A CN111000913 A CN 111000913A CN 201910588043 A CN201910588043 A CN 201910588043A CN 111000913 A CN111000913 A CN 111000913A
Authority
CN
China
Prior art keywords
solution
stirring
parts
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910588043.9A
Other languages
Chinese (zh)
Inventor
胡海峰
李彻
刘�英
朱薇
姜锦锦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sinopharm Health Industry Institute Co ltd
Original Assignee
Sinopharm Health Industry Institute Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinopharm Health Industry Institute Co ltd filed Critical Sinopharm Health Industry Institute Co ltd
Publication of CN111000913A publication Critical patent/CN111000913A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Abstract

The invention relates to a traditional Chinese medicine composition for treating psoriasis and a preparation thereof, wherein the traditional Chinese medicine composition comprises the following traditional Chinese medicine components: six Chinese herbal medicines such as garden burnet, lithospermum, madder, tree peony bark, angelica dahurica, liquorice and the like; the composition is extracted by alcohol to obtain alcohol extract, and the extract is added with corresponding pharmaceutical or cosmetic auxiliary materials to prepare preparation products such as hydrogel, emulsion, ointment and the like, and has the effect of remarkably treating psoriasis of mice. The Chinese medicinal compound composition for treating psoriasis has good activity for treating psoriasis, and can be applied to the treatment of psoriasis.

Description

Traditional Chinese medicine composition for treating psoriasis
Technical Field
The invention relates to the field of cosmetics and medicines, in particular to the field of prevention and treatment of psoriasis.
Background
Psoriasis is commonly called as psoriasis, is a chronic inflammatory skin disease, has long course of disease and easy recurrence tendency, and some cases are not cured almost for the whole life. The disease is mainly developed in young and old years, and has great influence on the physical health and mental conditions of patients. The clinical manifestations mainly include erythema and scales, all diseases occur in the whole body, the scalp and limbs are more common, and the symptoms are aggravated in winter. Psoriasis vulgaris is the most common type I, and is frequently attacked acutely; the typical manifestations are erythema with clear border and different shapes and sizes, and inflammatory halos around; slightly infiltrating and thickening; covering a plurality of layers of silvery scales on the surface; the scales are easy to scrape off, and after scraping, the scales are reddish and shiny, and a small bleeding point (Auspitz character) can be seen when the scales are scraped off. Psoriasis is also known as psoriatic arthritis. Patients with psoriasis suffer rheumatoid arthritis-like joint damage, which can affect the large and small joints of the whole body, but the disease is most characterized by the joint lesion between the distal finger (toe) joints; the affected joint is red, swollen and painful, and the skin around the joint is also red and swollen; the joint symptoms are usually aggravated or alleviated simultaneously with the skin symptoms, and the blood rheumatoid factor is negative. The externally applied medicine for treating psoriasis comprises:
(1) vitamin D3 analogs. The medicine comprises calcipotriol, tacalcitol and the like, and has good curative effect on plaque psoriasis. The composition can be used in combination with glucocorticoid or UVB to improve therapeutic effect. It should be used with cautions for patients with bone diseases, calcium metabolism disorder and renal insufficiency to avoid hypercalcemia. (2) A glucocorticoid. Topical glucocorticoids remain the current therapy commonly used to treat psoriasis. The strong hormone is suitable for the head and palms and soles, while the weak hormone is suitable for the face and the wiping area. Ointments and creams are commonly used for the general part. The head is applied with solution (propylene glycol) and gel. (3) Anthralin. It is commonly used for chronic plaque psoriasis. Can be made into ointment, paste and paraffin. The common concentration is 0.05-1.0%, and the concentration is gradually increased from low concentration according to the tolerance condition of patients. (4) Tretinoin. Gels and creams (0.05-0.1%) are effective against psoriasis when applied externally 1 or 2 times a day. Because of its slow onset of action, it is generally not used alone as a first-line drug. Can be used in combination with glucocorticoid such as clobetasol propionate, and the like, and the tazarotene is continuously applied after the skin damage is controlled, and the glucocorticoid is gradually stopped. Pregnant women, women in lactation and recent childbearing period are forbidden. (5) Tar oils. The common tar comprises coal tar, pine tar oil, bran distillate oil, black soybean distillate oil, etc., and is formulated into ointment with concentration of 5% for external use. The coal tar has good curative effect on chronic stable psoriasis, scalp psoriasis and palmoplantar psoriasis. Is not suitable for pregnant women, psoriasis of pustule type and erythrodermic type. The soluble coal tar can be used for bathing, and the coal tar shampoo is used for washing hair. The spirit of coal tar is used for applying and is effective in treating psoriasis on head. (6) Immunosuppressant and other external drugs. Such as tacrolimus, pimecrolimus external treatment and package treatment for intractable localized psoriasis. Camptothecin ointment 0.03%, salicylic acid ointment 5%, etc. Can also be used for treating psoriasis with Chinese medicinal materials, compound indigo naturalis pill, radix Tripterygii Wilfordii, compound Saviae Miltiorrhizae radix tablet, etc.
Some Chinese medicinal materials have various anti-inflammatory active ingredients, show strong anti-inflammatory activity in vivo and in vitro, and particularly show synergistic anti-inflammatory activity of Chinese medicinal compound materials such as sanguisorba, lithospermum, moutan bark, madder, angelica dahurica, liquorice and the like. These anti-inflammatory herbs are briefly introduced below:
sanguisorba officinalis (Latin scientific name: Sanguisorba officinalis L.) is a perennial herb of Sanguisorba of Rosaceae, and has spindle-shaped thick and strong heels, petiole brachypodium, mauve petals and fruit occluded in a calyx tube. Also named as Huangzhuyang, Yuzhang, Yufermented soya beans or Haematitum. Sanguisorba root, a little cold in nature and bitter in taste, is used as a medicine. The modern medical research proves that the garden burnet has the functions of stopping bleeding, cooling blood, clearing away heat and toxic materials, astringing to arrest diarrhea, resisting inflammation and inhibiting various pathogenic microorganisms, and can treat diseases such as hematemesis, bloody flux, burn, eczema, upper gastrointestinal hemorrhage, ulcer hemorrhage, hematochezia, metrorrhagia, tuberculous abscess, chronic osteomyelitis and the like. The sanguisorba contains about 17% of tannin and 2.5-4.0% of triterpenoid saponin. The saponins separated out are as follows: sanguisorba glucoside I, which is hydrolyzed to generate pomolic acid, arabinose and glucose; sanguisorba glucoside II is hydrolyzed to generate pomolic acid and arabinose; diospyros kaki saponin B is the triterpenoid saponin of glucuronic acid through preliminary identification. The effective component of the anti-inflammatory effect of the theine is 3, 3', 4-tri-O-methyl gallic acid, 4mg of tannin is applied to the ear of the mouse by ground transfusion, thus obviously inhibiting the croton oil induced auricle swelling, and the compound is orally taken for 1 g/(kg. d) and continuously 4d, thus effectively inhibiting the croton oil induced auricle swelling.
The other names of the lithospermum are as follows: radix Arnebiae, and radix Arnebiae. Is a Chinese medicinal herb recorded in Chinese pharmacopoeia, and the medicinal source is dry root of arnebia euchroma (Royle) Johnst, Lithospermum erythrorhizon or Lithospermum nakai of Boraginaceae. Shi Zi Cao is sweet, salty and cold in nature. It enters heart and liver meridians. Has the functions of cooling blood, promoting blood circulation, detoxifying and promoting eruption. The ethyl ether, ethanol or water extract of radix Arnebiae, alkannin, acetylalkannin, etc. can be administered orally or topically to inhibit hyperfunction of capillary permeability (including those caused by histamine, bromelain, bradykinin, and anti-rat serum and rabbit serum), and also can inhibit local edema of animal or peritonitis of mice caused by formaldehyde caused by carrageenan, anti-rat serum, rabbit serum, formaldehyde and heat stimulation. And inhibiting subcutaneous cotton ball granuloma hyperplasia, which shows that the composition has antagonism on vascular hyperpermeability, exudation and edema in acute exudation stage of inflammation and inflammation in proliferation stage. The removal of adrenal gland still has anti-inflammatory effect.
Moutan bark, cortex moutan, Chinese medicine name. Is dried root bark of Paeonia suffruticosa Andr. It is mostly distributed in Anhui, Sichuan, Gansu, Shaanxi, Hubei, Hunan, Shandong, Guizhou, etc. It is hard and brittle, and is easy to break, and its section is relatively flat, light pink and powdery. Fragrant smell, slightly bitter and astringent taste. Digging root in autumn, removing fine root, peeling root bark, and sun drying. Unprocessed or stir-baked. Compendium of materia Medica: nourishing yin to reduce pathogenic fire, removing speckle and toxic materials, relieving sore throat, and promoting urination. Later people only use Huang Ji to treat inflammation, but not know that the action of Dan Pi is better. Those with red flower are good, those with white flower are tonified, and those with white flower are rarely comprehended. Modern researches show that paeonol and other glycoside components have anti-inflammatory effect; the methanol extract of cortex moutan has platelet inhibiting effect; paeonol has central inhibitory effect on tranquilizing mind, lowering temperature, relieving fever, relieving pain, relieving spasm, etc., and has effects of resisting atherosclerosis, diuresis, and ulcer.
Madder (scientific name: Rubia cordifolia L.): rubiaceae, Rubia perennial grass climbing vine. Rubia cordifolia, being cold in nature and entering blood system, can cool blood and stop bleeding, and resolve blood stasis. It is indicated for bleeding due to recklessly blood flow due to blood heat. Cool blood and activate blood, dispel stasis, dredge meridians. Can be used for treating hematemesis, epistaxis, metrorrhagia, traumatic hemorrhage, amenorrhea, blood stasis, arthralgia, and traumatic injury with swelling and pain. Cooling blood to stop bleeding, promoting blood circulation to remove blood stasis: it can stop bleeding without retaining stasis, and is indicated for bleeding due to heat syndrome, amenorrhea and abdominal pain, and traumatic injury. The cuttlefish bone has stronger haemostasis.
The root of the dahurian angelica root is conical, the length of the dahurian angelica root is 10-20 cm, and the diameter of the dahurian angelica root is 2-2.5 cm. The surface is gray brown, and has transverse protruded skin holes and concave stem marks at the top. Hard, white cross section, enough powder, and densely covered brown oil spots on the skin. The nature and taste are warm, pungent, fragrant and slightly bitter; the functions mainly comprise expelling wind-damp, promoting blood circulation and expelling pus, promoting granulation and relieving pain. Can be used for treating headache, toothache, nasosinusitis, hemorrhoid, leucorrhea with red and white discharge, carbuncle, cellulitis, pyocutaneous disease, and skin pruritus.
Licorice (scientific name: Glycyrrhiza uralensis Fisch) alternative name: radix Angelicae Dahuricae, radix Glycyrrhizae, and radix Glycyrrhizae. Leguminous and glycyrrhiza herbs belong to perennial herbs, and the roots and the rhizomes are strong, so the Chinese herbal medicine is a tonifying Chinese herbal medicine. Has antiinflammatory, antiviral, liver protecting, toxic materials clearing away, and immunity enhancing effects. Because glycyrrhizic acid has glucocorticoid-like pharmacological action and no serious adverse reaction, the glycyrrhizic acid is widely used for clinically treating various acute and chronic hepatitis, bronchitis and AIDS, and also has the functions of resisting and preventing cancers, an interferon inducer, a cellular immunomodulator and the like. Glycyrrhizic acid has effects of reducing blood lipid and resisting atherosclerosis, and can prevent atherosclerosis. Licorice is the most commonly used medicine in clinic. The raw licorice can clear away heat and toxic materials, moisten lung and relieve cough, and harmonize the property of the medicines; prepared licorice root, radix Glycyrrhizae Praeparata has the effect of tonifying spleen and qi.
Chinese patent CN102727826A discloses a Chinese medicinal granule for treating psoriasis and a preparation process thereof, wherein a Chinese medicinal extract is prepared from a compound composition of Chinese medicinal materials such as honeysuckle flower, abalone shell, tree peony bark, dyers woad leaf, long pepper, spreading hedyotis herb, rehmannia root and turmeric by a secondary boiling water extraction method, and the Chinese medicinal granule is further prepared into the Chinese medicinal granule for treating psoriasis and has better effect of treating psoriasis. Chinese patent CN103655814B discloses a Chinese medicinal composition for treating psoriasis and application thereof, and also adopts oil extracts of three herbal compositions of lithospermum, madder, liquorice and the like to have the effect of treating psoriasis. Chinese patent CN106924378 discloses a lipstick for preventing or/and treating chronic cheilitis, which is prepared from a composition of three herbs including alkanna tinctoria, madder root, licorice root and the like by a secondary boiling water extraction method to prepare traditional Chinese medicine extracts, and further preparing a medicinal lipstick preparation with anti-inflammatory activity. Has better effect of treating chronic cheilitis.
The existing animal models are started with the three pathological links, and simulate partial pathological characteristics of psoriasis at different angles and levels, wherein a mouse psoriasis model induced by imiquimod is common, the imiquimod is a TLR7 agonist and an 8 agonist, can be combined with BALB/c mouse epidermal plasmacytes pDC and TLR7 in macrophages, secretes factors such as IFN- α, IL-23, IL-17 and the like, induces the epidermis to have histopathological changes such as hyperkeratosis and parakeratosis, thick spinous layer, inflammatory cell infiltration and the like, and is suitable for evaluating the effect of psoriasis treatment medicines.
The optimal formula is obtained by optimizing and screening multiple Chinese herbal medicine compounds, the optimal formula has the optimal effect of treating psoriasis, the composite anti-inflammatory activity of six Chinese herbal medicines of the garden burnet, the lithospermum, the moutan bark, the madder, the angelica dahurica, the liquorice and the like in the optimal Chinese herbal medicine composition screened according to the psoriasis model is stronger than the anti-inflammatory activity of a single medicinal material and stronger than the anti-inflammatory activity of three herbal medicine compositions of the lithospermum, the madder, the liquorice and the like, the remarkable advantage of multi-component synergistic anti-inflammatory of the Chinese herbal medicine is reflected, and the compound Chinese herbal medicine has.
Disclosure of Invention
In order to improve the effect of Chinese herbal medicines for treating psoriasis in the prior art and further optimize the traditional Chinese medicine compound for treating psoriasis, which is reported in the prior literature and takes the lithospermum, the madder and the liquorice as main components, the inventor discovers a new composition through a large number of animal experiments, has better synergistic effect, can improve the anti-inflammatory activity of the traditional Chinese medicine composition, and can also improve the effect of the traditional Chinese medicine composition for treating psoriasis. The traditional Chinese medicine raw materials used in the invention are all traditional Chinese medicine materials with small toxic and side effects, which are widely used clinically, and the product has good safety and can be used for a long time.
The invention provides a traditional Chinese medicine composition for treating psoriasis, which comprises the following components in percentage by mass: 10-45% of garden burnet root, 10-45% of lithospermum, 5-25% of madder root, 0-25% of tree peony bark, 0-20% of angelica dahurica and 5-25% of liquorice.
Preferably, the composition comprises the following components in percentage by mass: 20-40% of garden burnet, 20-40% of lithospermum, 10-25% of madder, 0-10% of moutan bark, 0-10% of angelica dahurica and 10-20% of liquorice.
Most preferably, the composition comprises the following components in percentage by mass: 25-30% of garden burnet, 25-30% of lithospermum, 15-20% of madder, 5-10% of moutan bark, 0-5% of angelica dahurica and 15-20% of liquorice.
The invention also provides a traditional Chinese medicine extract for treating psoriasis, which is prepared by the following method: weighing 1 part of any one of the traditional Chinese medicine compositions, adding 10 times of alcohol solvent, soaking for 12 hours, heating to 80 ℃, and performing reflux extraction for 2 hours; filtering, adding 10 times of alcohol solvent into the residue, heating and reflux extracting for 2 hr; filtering, mixing the two ethanol solvent extracts, and concentrating under reduced pressure in 50 deg.C water bath to obtain pulp.
The alcohol solvent comprises small molecular aliphatic alcohols such as methanol, ethanol, isopropanol and the like, and ethanol is preferred.
The invention also provides an external plaster preparation for treating psoriasis, which is characterized in that the plaster is prepared by the following method: 1) weighing 1 part of synthetic wax, 3 parts of ozokerite and 3 parts of synthetic beeswax, respectively heating in a water bath at 80 ℃, stirring, dissolving, and then mixing to obtain solution A;
2) weighing BHT0.5 parts, lanolin 2.5 parts, and white vaseline 2.5 parts, heating in 80 deg.C water bath, stirring for dissolving, adding solution A, stirring, and mixing to obtain solution B
3) Weighing 0.5 part of caprylic triglyceride, 14 parts of the traditional Chinese medicine extract for treating psoriasis, 2 parts of glycerol and 1 part of essence, heating in a water bath at 80 ℃, stirring and mixing uniformly, adding the solution B, mixing and stirring uniformly to obtain a solution C;
4) and (4) introducing the solution C into a glass bottle or other metal tubes while the solution C is hot, and cooling to obtain a plaster preparation product.
The invention also provides an external hydrogel preparation for treating psoriasis, which is characterized by being prepared by the following method:
1) weighing 0.3 part of carbomer 940, adding 4.0 parts of deionized water, stirring and soaking for 6-12 hours, and uniformly mixing to obtain a carbomer solution A;
2) weighing 2 parts of the traditional Chinese medicine extract for treating psoriasis, 1.5 parts of glycerol and 1.5 parts of absolute ethyl alcohol, heating in a water bath at 60 ℃, stirring, dissolving, adding the solution A, stirring and mixing uniformly to obtain solution B;
3) weighing 0.5 part of azone, 0.2 part of allantoin and 0.5 part of essence, stirring and mixing uniformly at normal temperature, adding the solution B, mixing and stirring uniformly, and homogenizing uniformly to obtain a hydrogel C solution;
4) weighing 0.1 part of triethylamine solution, slowly dropwise adding the triethylamine solution into the solution C while stirring, and adjusting the viscosity of the hydrogel to 20 pas to obtain the external hydrogel preparation.
The traditional Chinese medicine composition for treating psoriasis and the preparation thereof can be prepared into common cosmetics, medicinal cosmetics and traditional Chinese medicine compound external preparations.
The reagents and starting materials used in the present invention are commercially available.
The sanguisorba comprises a sanguisorba root medicinal material, a traditional Chinese medicine decoction piece, sanguisorba root powder or an extract thereof; the radix Arnebiae is selected from radix Arnebiae medicinal material, Chinese medicinal decoction pieces, and herba Arnebiae powder or its extract; the cortex moutan comprises cortex moutan traditional Chinese medicinal materials, Chinese medicinal decoction pieces, cortex moutan powder and extracts thereof; the madder is a whole madder comprising traditional Chinese medicinal materials, traditional Chinese medicine decoction pieces and an extract; the radix Angelicae Dahuricae is radix Angelicae Dahuricae including radix Angelicae Dahuricae Chinese medicinal material, Chinese medicinal decoction pieces, radix Angelicae Dahuricae root powder and its extract; the Glycyrrhrizae radix is Glycyrrhrizae radix including Glycyrrhrizae radix Chinese medicinal material, Chinese medicinal decoction pieces, Glycyrrhrizae radix powder and its extract.
The positive progress effects of the invention are as follows: the traditional Chinese medicine composition for preventing or treating psoriasis provided by the invention is rationally designed, and has a large amount of data screened by animal experiments, so that the synergistic effect of the six medicinal materials is good; the medicinal materials are all nontoxic medicinal materials, so that the safety is good, the formula is simpler, the quality control is easy, and the key point is that the more excellent anti-inflammatory effect can be achieved.
Detailed Description
The present invention is further illustrated by the following examples, which are not intended to limit the scope of the invention, and the experimental procedures not described in the following examples are all conventional experimental procedures, and are performed in accordance with the commercial specifications.
The formula of the traditional Chinese medicine compound composition for treating psoriasis comprises the following steps:
TABLE 1 formulations of examples 3-8
Example numbering Radix Sanguisorbae Lithospermum erythrorhizon Cortex moutan Root of India madder Root of Dahurian Angelica Licorice root, radix Glycyrrhizae Kind of alcohol
3 10 45 0 25 0 20 Methanol
4 20 30 10 15 0 25 Ethanol
5 30 20 20 10 10 10 Ethanol
6 20 30 20 10 10 10 Ethanol
7 45 10 10 5 20 10 Propanol(s)
8 45 10 25 5 10 5 Methanol
Example 1:
according to the Chinese patent CN106924378, 40 g of lithospermum, 20g of madder and 20g of liquorice are weighed, and are added with 2400ml of water (30 times) to be soaked in boiling water for extraction for 2 hours; vacuum filtering, extracting the residue with 1600ml boiling water for 2 hr, filtering, mixing the two supernatants, and concentrating under reduced pressure at 60 deg.C to density of 1.10g/cm3Thus obtaining the extract of the Chinese medicinal composition.
Example 2:
according to the Chinese patent CN103655814B, weighing 32 g of lithospermum, 32 g of madder and 28 g of liquorice, adding 600g of olive oil, soaking for 48 hours, then frying for 8 hours with slow fire, filtering dregs of a decoction, and cooling the oil formula to obtain the extract of the traditional Chinese medicine compound.
Example 3:
weighing 10g of garden burnet, 45 g of lithospermum, 0g of moutan bark, 25 g of madder, 0g of angelica dahurica and 20g of liquorice according to the table 1 respectively, adding 1000ml (10 times) of methanol, soaking for 12 hours, and heating to 80 ℃ for extraction for 2 hours; filtering, adding 1000ml (10 times) of methanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the two methanol extracts to obtain methanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 4:
weighing 20g of garden burnet, 30 g of lithospermum, 10g of moutan bark, 15 g of madder, 0g of angelica dahurica and 25 g of liquorice respectively according to the table 1, adding 1000ml (10 times) of ethanol, soaking for 12 hours, and heating to 80 ℃ for extraction for 2 hours; filtering, adding 1000ml (10 times) of ethanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the secondary ethanol extracts to obtain ethanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 5:
weighing 30 g of garden burnet, 20g of lithospermum, 20g of moutan bark, 10g of madder, 10g of angelica dahurica and 10g of liquorice respectively according to the table 1, adding 1000ml (10 times) of ethanol, soaking for 12 hours, and heating to 80 ℃ for extraction for 2 hours; filtering, adding 1000ml (10 times) of ethanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the secondary ethanol extracts to obtain ethanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 6:
weighing 20g of garden burnet, 30 g of lithospermum, 20g of moutan bark, 10g of madder, 10g of angelica dahurica and 10g of liquorice respectively according to the table 1, adding 1000ml (10 times) of ethanol, soaking for 12 hours, and heating to 80 ℃ for extraction for 2 hours; filtering, adding 1000ml (10 times) of ethanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the secondary ethanol extracts to obtain ethanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 7
Weighing 45 g of garden burnet, 10g of lithospermum, 10g of moutan bark, 5 g of madder, 20g of angelica dahurica and 10g of liquorice respectively according to the table 1, adding 1000ml (10 times) of ethanol, soaking for 12 hours, heating to 80 ℃ and extracting for 2 hours; filtering, adding 1000ml (10 times) of ethanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the secondary ethanol extracts to obtain ethanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 8
Weighing 45 g of garden burnet, 10g of lithospermum, 25 g of moutan bark, 5 g of madder, 10g of angelica dahurica and 5 g of liquorice respectively according to the table 1, adding 1000ml (10 times) of ethanol, soaking for 12 hours, heating to 80 ℃ and extracting for 2 hours; filtering, adding 1000ml (10 times) of ethanol into the residue, and heating and extracting for 2 hours; filtering, and mixing the secondary ethanol extracts to obtain ethanol extract of Chinese medicinal composition; concentrating under reduced pressure in 50 deg.C water bath to obtain pulp to obtain Chinese medicinal extract.
Example 9: preparation of plaster
Weighing 1 part of synthetic wax, 3 parts of ozokerite and 3 parts of synthetic beeswax, respectively heating in a water bath at 80 ℃, stirring, dissolving, and mixing to obtain solution A; weighing 0.5 part of BHT (2, 6-di-tert-butyl-p-cresol), 2.5 parts of lanolin and 2.5 parts of white vaseline, heating in a water bath at 80 ℃, stirring, dissolving, adding the solution A, and uniformly stirring and mixing to obtain solution B; weighing 0.5 part of caprylic triglyceride, 14 parts of Chinese medicinal extract, 2 parts of glycerol and 1 part of essence, heating in a water bath at 80 ℃, stirring and mixing uniformly, adding the solution B, mixing and stirring uniformly to obtain a solution C; and (4) introducing the solution C into a tube while the solution C is hot to prepare the plaster preparation.
Example 10: preparation of hydrogel formulations
1) Weighing 0.3 part of carbomer 940, adding 4.0 parts of deionized water, stirring and soaking for 6-12 hours, and uniformly mixing to obtain a carbomer solution A;
2) weighing 2 parts of traditional Chinese medicine extract, 1.5 parts of glycerol and 1.5 parts of absolute ethyl alcohol, heating in a water bath at 60 ℃, stirring and dissolving, adding the solution A, stirring and mixing uniformly to obtain solution B;
3) weighing 0.5 part of azone, 0.2 part of allantoin and 0.5 part of essence, stirring and mixing uniformly at normal temperature, adding the solution B, mixing and stirring uniformly, and homogenizing uniformly to obtain a hydrogel C solution;
4) weighing 0.1 part of triethylamine solution, slowly dropwise adding the triethylamine solution into the solution C while stirring, and adjusting the viscosity of the hydrogel to 20 pas to obtain the external hydrogel preparation.
Example 11: psoriasis treatment effect experiment
The following mouse psoriasis model efficacy evaluation was performed on the Chinese medicinal compositions prepared in examples 1 to 8 by mouse test.
Medicaments and agents
Imiquimod cream, halomethasone (positive control), are all commercially available.
The test composition, using the extracts (extractum) of the chinese traditional medicine prepared in examples 1 to 8, was prepared into a plaster or hydrogel formulation according to the method of example 9 or 10, specifically:
product 1: a hydrogel preparation prepared from the extract of the Chinese medicinal material of example 1;
2-3 of products: plaster preparations prepared from the extracts of the Chinese herbs of examples 2 and 3, respectively;
4-8 parts of product: hydrogel formulations were prepared using the herbal extracts of examples 4-8, respectively.
Laboratory animal
BALB/c mice, SPF grade, males, weighing around 22 g. The experimental animal is provided by Shanghai Sphere-BiKai experimental animals Co., Ltd, and the animal production license number: SCXK (Shanghai) 2013-0016. 10 animals are raised in each cage, the room temperature of the animals is set to be 20-22 ℃, the humidity is set to be 40% -70%, and the animals are alternately illuminated in light and shade for 12 hours. The padding is replaced at least 2 times per week, the feeding box is replaced at the same time, and the feeding box is replaced at any time when abnormal conditions occur.
Preparing an animal model: BALB/c mice were anesthetized by intraperitoneal injection with 1% chloral hydrate (0.2ml/20g), their back hairs were shaved off to form an exposed area of 2cm by 3cm in size, and the mice were housed in individual cages for 1d and then treated with drugs in groups.
Experimental methods
1) Animal grouping: the mice were randomly divided into 10 groups, which were 10 groups, i.e., a model group, a halometasone group (positive drug), a product 1 group, a product 2 group, a product 3 group, a product 4 group, a product 5 group, a product 6 group, a product 7 group, and a product 8 group, respectively.
2) Dosage and method of administration:
normal group: not processing;
model group: mice were regularly coated with imiquimod on their bare backs in the morning 1 time a day. Smearing blank matrix in the afternoon, twice a day for 8 consecutive days, and the administration dosage is shown in Table 3;
halometasone group: mice were regularly coated with imiquimod on their bare backs in the morning 1 time a day. The positive drug halometasone is applied and administered at regular time in the afternoon, 2 times a day, and the administration is continuously performed for 8 days, and the administration dosage is shown in table 3;
products 1-8 dosing groups: mice were regularly coated with imiquimod on their bare backs in the morning 1 time a day. The corresponding product is applied by smearing at fixed time in the afternoon for 2 times a day for 8 days, and the administration dosage is shown in table 3;
TABLE 3 dosage of administration
Imiquimod Halometasone 1-8 products
20mg/cm2 10mg/cm2 0.238g/cm2
3) The detection indexes and the method are as follows:
① according to the evaluation standard of psoriasis skin lesion area and disease severity (PASI) of each group of mice, the integration of corresponding erythema, scale and infiltration thickening degree is given to the mice, the integration of the three is added to obtain the total integration, the change condition of the skin lesion of the mice is observed, and the evaluation standard is shown in the following table 4.
TABLE 4 psoriasis lesion severity score
Figure BDA0002115127430000101
② cutting back skin of each group of mice, slicing, HE staining, taking pictures under 20 Xobjective lens, and measuring and counting thickness of three parts of epidermis by ImageJ (1.49V, NIH) picture processing software;
results of the experiment
TABLE 4 psoriasis lesion severity score
Group of Thickening of soil Erythema Scale and chip Total score Cortex thickness (μm)
Normal group 0 0 0 0 18.03±2.32
Model set 2.25±0.75 1.50±0.5 2.50±0.5 6.25±0.75 99.33±10.37
Halometasone group 0 0.6±0.4 1.8±0.6 2.4±0.8 59.89±5.71
Product 1 group 0.25±0.75 1.25±0.75 1.5±0.4 3.0±0.8 47.05±3.12
Product 2 group 0.2±0.7 1.8±0.7 1.4±0.7 3.4±0.9 60.99±6.77
Product 3 groups 0.5±0.2 0 0 0.5±0.2 52.28±4.10
Product 4 groups 0.2±0.1 0.5±0.3 0 0.7±0.3 43.57±3.44
Product 5 groups 0.1±0.1 0.3±0.2 1.0±0.4 1.4±0.6 60.10±5.31
Product 6 groups 0 0.5±0.3 0 0.5±0.2 55.76±4.71
Product 7 groups 0.1±0.1 0.3±0.1 0.5±0.2 0.8±0.2 43.57±2.18
Product 8 groups 0 0.3±0.2 0.5±0.1 0.8±0.4 46.84±3.40
According to the experimental data, the product 1-2 groups are control groups, and the product 3-8 groups show stronger psoriasis treatment efficacy than the control groups, so that the six-ingredient traditional Chinese medicine compound composition has better effect than the three-herb composition, and has stronger psoriasis treatment efficacy.

Claims (9)

1. A traditional Chinese medicine composition for treating psoriasis comprises the following components in percentage by mass: 10-45% of garden burnet root, 10-45% of lithospermum, 5-25% of madder root, 0-25% of tree peony bark, 0-20% of angelica dahurica and 5-25% of liquorice.
2. The traditional Chinese medicine composition for treating psoriasis according to claim 1 comprises the following components in percentage by mass: 20-40% of garden burnet, 20-40% of lithospermum, 10-25% of madder, 0-10% of moutan bark, 0-10% of angelica dahurica and 10-20% of liquorice.
3. The traditional Chinese medicine composition for treating psoriasis according to claim 1, which comprises the following components in percentage by mass: 25-30% of garden burnet, 25-30% of lithospermum, 15-20% of madder, 5-10% of moutan bark, 0-5% of angelica dahurica and 15-20% of liquorice.
4. The traditional Chinese medicine extract for treating psoriasis is characterized by being prepared by the following method: soaking the Chinese medicinal composition of any one of claims 1-3 in 10 times of alcohol solvent for 12 hr, heating to 80 deg.C, and reflux-extracting for 2 hr; filtering, adding 10 times of alcohol solvent into the residue, heating and reflux extracting for 2 hr; filtering, mixing the two ethanol solvent extracts, and concentrating under reduced pressure in 50 deg.C water bath to obtain pulp.
5. The extract of Chinese herbs according to claim 4, wherein the alcohol solvent comprises small molecular aliphatic alcohols such as methanol, ethanol, isopropanol, etc., preferably ethanol.
6. Use of a Chinese medicinal composition or extract according to any one of claims 1 to 5 in the manufacture of a cosmetic or pharmaceutical preparation for the treatment of psoriasis.
7. The use of claim 6, wherein the formulation comprises a hydrogel, an emulsion, an ointment, or a plaster.
8. The use according to claim 6, wherein the pharmaceutical or cosmetic composition further comprises pharmaceutically or cosmetically acceptable adjuvants.
9. A plaster preparation for external use for treating psoriasis, which is characterized in that the plaster is prepared by the following method:
1) weighing 1 part of synthetic wax, 3 parts of ozokerite and 3 parts of synthetic beeswax, respectively heating in a water bath at 80 ℃, stirring, dissolving, and then mixing to obtain solution A;
2) weighing 0.5 part of BHT, 2.5 parts of lanolin and 2.5 parts of white vaseline, heating in a water bath at 80 ℃, stirring for dissolving, adding the solution A, and stirring and mixing uniformly to obtain solution B;
3) weighing 0.5 part of caprylic triglyceride, 14 parts of the traditional Chinese medicine extract as claimed in claim 4, 2 parts of glycerol and 1 part of essence, heating in a water bath at 80 ℃, stirring and mixing uniformly, adding the solution B, mixing and stirring uniformly to obtain a solution C;
4) and (4) introducing the solution C into a glass bottle or other metal tubes while the solution C is hot, and cooling to obtain a plaster preparation product. An external hydrogel formulation for treating psoriasis, wherein the hydrogel formulation is prepared by the following method:
1) weighing 0.3 part of carbomer 940, adding 4.0 parts of deionized water, stirring and soaking for 6-12 hours, and uniformly mixing to obtain a carbomer solution A;
2) weighing 2 parts of the traditional Chinese medicine extract of claim 4, 1.5 parts of glycerol and 1.5 parts of absolute ethyl alcohol, heating in a water bath at 60 ℃, stirring and dissolving, adding the solution A, stirring and mixing uniformly to obtain solution B;
3) weighing 0.5 part of azone, 0.2 part of allantoin and 0.5 part of essence, stirring and mixing uniformly at normal temperature, adding the solution B, mixing and stirring uniformly, and homogenizing uniformly to obtain a hydrogel C solution;
4) weighing 0.1 part of triethylamine solution, slowly dropwise adding the triethylamine solution into the solution C while stirring, and adjusting the viscosity of the hydrogel to 20 pas to obtain the external hydrogel preparation.
CN201910588043.9A 2018-10-08 2019-07-02 Traditional Chinese medicine composition for treating psoriasis Pending CN111000913A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2018111568350 2018-10-08
CN201811156835.0A CN109125443A (en) 2018-10-08 2018-10-08 A kind of Chinese medicine composition for treating psoriasis

Publications (1)

Publication Number Publication Date
CN111000913A true CN111000913A (en) 2020-04-14

Family

ID=64814139

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201811156835.0A Withdrawn CN109125443A (en) 2018-10-08 2018-10-08 A kind of Chinese medicine composition for treating psoriasis
CN201910588043.9A Pending CN111000913A (en) 2018-10-08 2019-07-02 Traditional Chinese medicine composition for treating psoriasis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201811156835.0A Withdrawn CN109125443A (en) 2018-10-08 2018-10-08 A kind of Chinese medicine composition for treating psoriasis

Country Status (1)

Country Link
CN (2) CN109125443A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024041084A1 (en) * 2022-08-23 2024-02-29 上海市皮肤病医院 External traditional chinese medicine composition for treating psoriasis, preparation method for, and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024041084A1 (en) * 2022-08-23 2024-02-29 上海市皮肤病医院 External traditional chinese medicine composition for treating psoriasis, preparation method for, and use thereof

Also Published As

Publication number Publication date
CN109125443A (en) 2019-01-04

Similar Documents

Publication Publication Date Title
CN103610926B (en) Traditional Chinese medicine freckle-removing compositions, traditional Chinese medicine freckle-removing preparation and traditional Chinese medicine freckle-removing facial film
CN103169928B (en) Externally applied traditional Chinese medicine composition for treating dysmenorrhea, as well as preparation method and application thereof
CN101468070A (en) Medicinal composition for treating acne and preparation method thereof
CN108938759B (en) Medicine or daily chemical product composition for treating hand-foot syndrome and preparation method and application thereof
CN106176784B (en) It is a kind of for the pharmaceutical composition of dermatitis, application, preparation and preparation method thereof
CN104013929B (en) Rheumatism pain relief medicine for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof
CN113768975A (en) Traditional Chinese medicine composition for treating arthralgia, traditional Chinese medicine patch, and preparation method and use method thereof
CN108403932B (en) Traditional Chinese medicine compound external preparation for treating hormone-dependent dermatitis and preparation method and application thereof
CN111000913A (en) Traditional Chinese medicine composition for treating psoriasis
CN111375038B (en) Traditional Chinese medicine bath composition for treating psoriasis as well as preparation method and application thereof
CN112057543B (en) A topical Chinese medicinal composition for treating acne, and its preparation method
CN102895387A (en) Kidney-yang-warming medicine composition, and preparation thereof and preparation method thereof
CN108721442B (en) Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof
CN103239674B (en) Antineoplastic traditional Chinese medicine composition and preparation method thereof
CN113244356A (en) Traditional Chinese medicine composition for treating psoriasis
CN105343847A (en) Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof
CN112675264B (en) Composition for treating psoriasis, preparation method and application thereof
CN104274584B (en) A kind of preparation method of hair growth Tibetan medicine
CN112755101B (en) Traditional Chinese medicine composition for treating knee osteoarthritis and application thereof
CN108653423A (en) A kind of Chinese medicine composition and its preparation prevented or treat chronic cheilitis
CN114617919B (en) Composition for treating eczema or urticaria, preparation method and pharmaceutical application thereof
CN112402565B (en) Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method thereof
CN102755519A (en) Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof
CN115154521B (en) Composition and preparation for treating psoriasis caused by external cold and internal heat and preparation method
CN112402566B (en) Application of traditional Chinese medicine composition in preparation of medicine for treating gonarthromeningitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination